Hesselink DA - Search Results

1

The relative importance of cyclosporine exposure in heart, kidney or liver transplant recipients on maintenance therapy.

Hesselink DA, van Dam T, Metselaar HJ, Balk AH, Mathôt RA, Smak Gregoor PJ, Weimar W, van Gelder T. Hesselink DA, et al. Transpl Int. 2004 Oct;17(9):495-504. doi: 10.1007/s00147-004-0733-4. Epub 2004 Aug 28. Transpl Int. 2004. PMID: 15338117 Free article.

2

[Kidney transplantation: more kidneys from living donors, individualised immunosuppression and better results].

van Gelder T, Hesselink DA, Roodnat JI, Ijzermans JN, Weimar W. van Gelder T, et al. Among authors: hesselink da. Ned Tijdschr Geneeskd. 2003 May 17;147(20):955-9. Ned Tijdschr Geneeskd. 2003. PMID: 12784528 Review. Dutch.

3

[Twenty-five years of cyclosporin use in transplantation medicine].

Hesselink DA, van Hagen PM, Balk AH, van Hal PT, Weimar W, van Gelder T. Hesselink DA, et al. Ned Tijdschr Geneeskd. 2003 May 17;147(20):959-64. Ned Tijdschr Geneeskd. 2003. PMID: 12784529 Review. Dutch.

4

The use of cyclosporine in renal transplantation.

Hesselink DA, Smak Gregoor PJ, Weimar W. Hesselink DA, et al. Transplant Proc. 2004 Mar;36(2 Suppl):99S-106S. doi: 10.1016/j.transproceed.2003.12.047. Transplant Proc. 2004. PMID: 15041316 Review.

5

Experience with cyclosporine in endogenous uveitis posterior.

Hesselink DA, Baarsma GS, Kuijpers RW, van Hagen PM. Hesselink DA, et al. Transplant Proc. 2004 Mar;36(2 Suppl):372S-377S. doi: 10.1016/j.transproceed.2004.01.003. Transplant Proc. 2004. PMID: 15041371 Review.

6

The effects of renal transplantation on circulating dendritic cells.

Hesselink DA, Vaessen LM, Hop WC, Schoordijk W, Ijzermans JN, Baan CC, Weimar W. Hesselink DA, et al. Clin Exp Immunol. 2005 May;140(2):384-93. doi: 10.1111/j.1365-2249.2005.02755.x. Clin Exp Immunol. 2005. PMID: 15807866 Free PMC article.

7

Functional impairment of monocyte-derived dendritic cells in patients with severe chronic kidney disease.

Verkade MA, van Druningen CJ, Vaessen LM, Hesselink DA, Weimar W, Betjes MG. Verkade MA, et al. Among authors: hesselink da. Nephrol Dial Transplant. 2007 Jan;22(1):128-38. doi: 10.1093/ndt/gfl519. Epub 2006 Sep 27. Nephrol Dial Transplant. 2007. PMID: 17005525

8

Kinetic analysis reveals potency of CD4+ CD25bright+ regulatory T-cells in kidney transplant patients.

Velthuis JH, Hesselink DA, Hendrikx TK, van der Mast BJ, Klepper M, de Greef GE, Baan CC, Weimar W. Velthuis JH, et al. Among authors: hesselink da. Transpl Immunol. 2007 Nov;18(2):159-65. doi: 10.1016/j.trim.2007.05.009. Epub 2007 Jun 18. Transpl Immunol. 2007. PMID: 18005862

9

Dosing tacrolimus based on CYP3A5 genotype: will it improve clinical outcome?

van Gelder T, Hesselink DA. van Gelder T, et al. Among authors: hesselink da. Clin Pharmacol Ther. 2010 Jun;87(6):640-1. doi: 10.1038/clpt.2010.42. Clin Pharmacol Ther. 2010. PMID: 20485320

10

Treatment of steroid-resistant acute renal allograft rejection with alemtuzumab.

van den Hoogen MW, Hesselink DA, van Son WJ, Weimar W, Hilbrands LB. van den Hoogen MW, et al. Among authors: hesselink da. Am J Transplant. 2013 Jan;13(1):192-6. doi: 10.1111/j.1600-6143.2012.04328.x. Epub 2012 Nov 21. Am J Transplant. 2013. PMID: 23167538 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

275 results

Search Page

Filters